about
Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxidesLicorice: a possible anti-inflammatory and anti-ulcer drugThe lipoxin A4 agonist BML-111 attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats.Flavocoxid attenuates gentamicin-induced nephrotoxicity in rats.Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling.Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.Allicin ameliorates kidney function and urinary bladder sensitivity in cyclosporine A-treated rats.Protective effect of allicin against gentamicin-induced nephrotoxicity in rats.The NF-κB inhibitor celastrol attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats.Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats.Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.Implication of Nrf2/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis.Influence of diltiazem and/or propranolol on rat blood glucose levels in normal and diabetic animals.Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats.Levocetirizine Pretreatment Mitigates Lipopolysaccharide-Induced Lung Inflammation in RatsEffect of Zinc on the Anti-Inflammatory and Ulcerogenic Activities of Indometacin and DiclofenacEffect of high lipid diet and allopurinol on the development of experimentally induced arthritis in ratsNilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progressionVildagliptin/pioglitazone combination improved the overall glycemic control in type I diabetic ratsCrocin reverses unilateral renal ischemia reperfusion injury-induced augmentation of oxidative stress and toll like receptor-4 activity
P50
Q21203554-2A1B2BC1-1FAF-4009-8A04-3966F65CFAC5Q37360681-308CD433-33A6-4F49-BE4A-456BF987BF32Q40390723-B0B9C529-EA1A-442E-8BCB-8749F163E0FFQ41052689-8E739469-4E89-4981-A310-AC3F5E0456A3Q45579826-C6B8673C-3E9D-470F-A919-E2DCEDDED98DQ46225596-3074257D-5B58-45A6-990F-354577DE155BQ46290740-73F47BC5-33D1-4683-BBA6-694927F89339Q46294675-967CAE95-7345-4CDA-BCBF-368CFFD7F5F8Q46684821-60D13054-8262-49F5-9484-96161FA1686FQ50153423-7C19923E-F75E-46A3-8FD0-C4A80774E709Q50850318-F7DB4273-6A88-4A4B-A12C-201FBC95584DQ51219327-DDC3EC23-3A04-4582-B10E-49C7EA511601Q51601767-A69A44A6-6980-4B2D-B6CB-4F30C4184226Q53780750-E524ACF3-9BA6-4CDD-AD6D-5E177AE2C7E5Q58785062-88EA79F8-66CA-4701-BEFE-6C1F1658658EQ70768583-2241A5E7-3B4D-488A-BF02-1275274B03D2Q71592281-5E3EFE70-5C00-41E8-9D41-A9AD5520EAB6Q84086537-BD0B8C50-8691-4D76-8E7A-63C288A11EBFQ87978830-F8DB2940-775A-4CB3-B4C6-F7C8D5F146A2Q88293387-8655D7B3-44CE-4320-AC93-40DD54FAFCA2
P50
description
researcher ORCID ID = 0000-0003-4429-1586
@en
name
Hatem A Salem
@ast
Hatem A Salem
@en
Hatem A Salem
@es
Hatem A Salem
@nl
type
label
Hatem A Salem
@ast
Hatem A Salem
@en
Hatem A Salem
@es
Hatem A Salem
@nl
prefLabel
Hatem A Salem
@ast
Hatem A Salem
@en
Hatem A Salem
@es
Hatem A Salem
@nl
P1153
9250812900
P31
P496
0000-0003-4429-1586